Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Immunovant
IMVT
$8.64B
| $4.34M | ﹤0.01% |
271,350
+119,809
| +79% | +$1.81M |
|
2227
Constellium
CSTM
$3.95B
| $4.34M | ﹤0.01% |
326,418
+137,734
| +73% | +$1.55M |
|
2228
Innospec
IOSP
$2.31B
| $4.33M | ﹤0.01% |
51,510
+15,023
| +41% | +$1.32M |
|
2229
Cracker Barrel
CBRL
$1.31B
| $4.31M | ﹤0.01% |
70,622
+31,203
| +79% | +$1.57M |
|
|
DVAX
2230
DELISTED
Dynavax Technologies
DVAX
| $4.31M | ﹤0.01% |
434,671
+197,256
| +83% | +$2.08M |
|
2231
O-I Glass
OI
$1.05B
| $4.3M | ﹤0.01% |
291,870
+95,050
| +48% | +$1.22M |
|
2232
CALL
IonQ
IONQ
$18.2B
| $4.3M | ﹤0.01% |
+100,000
| New | +$3.35M |
|
|
WRD
2233
WeRide Inc
WRD
$1.96B
| $4.29M | ﹤0.01% |
544,423
+541,742
| +20,207% | +$4.83M |
|
2234
PUT
SoundHound AI
SOUN
$3.32B
| $4.28M | ﹤0.01% |
398,800
-360,000
| -47% | -$3.39M |
|
2235
NovaGold Resources
NG
$3.4B
| $4.28M | ﹤0.01% |
1,046,184
+156,040
| +18% | +$584K |
|
|
CURB
2236
Curbline Properties
CURB
$3.46B
| $4.27M | ﹤0.01% |
187,174
+65,444
| +54% | +$1.51M |
|
2237
CALL
Crane Co
CR
$12.7B
| $4.27M | ﹤0.01% |
+22,500
| New | +$3.73M |
|
2238
Garrett Motion
GTX
$5.35B
| $4.27M | ﹤0.01% |
406,402
+167,616
| +70% | +$1.69M |
|
2239
Cousins Properties
CUZ
$4.93B
| $4.24M | ﹤0.01% |
141,341
+42,425
| +43% | +$1.2M |
|
2240
PUT
Kohl's
KSS
$2.22B
| $4.24M | ﹤0.01% |
500,000
+438,100
| +708% | +$3.37M |
|
2241
Valmont Industries
VMI
$9.5B
| $4.23M | ﹤0.01% |
12,942
+306
| +2% | +$93.8K |
|
2242
Adaptive Biotechnologies
ADPT
$3.89B
| $4.22M | ﹤0.01% |
362,634
+158,664
| +78% | +$1.44M |
|
2243
Kosmos Energy
KOS
$1.51B
| $4.22M | ﹤0.01% |
2,450,929
-77,773
| -3% | -$141K |
|
2244
CALL
Madrigal Pharmaceuticals
MDGL
$11.7B
| $4.21M | ﹤0.01% |
+13,900
| New | +$4.14M |
|
2245
CALL
Bloom Energy
BE
$69.6B
| $4.19M | ﹤0.01% |
175,000
| – | – |
|
2246
B2Gold
BTG
$6.7B
| $4.18M | ﹤0.01% |
1,158,518
+264,304
| +30% | +$867K |
|
|
AIV
2247
Aimco
AIV
$379M
| $4.18M | ﹤0.01% |
482,863
+64,313
| +15% | +$520K |
|
2248
Loar Holdings
LOAR
$6.93B
| $4.17M | ﹤0.01% |
48,416
+9,653
| +25% | +$835K |
|
|
SFD
2249
Smithfield Foods
SFD
$8.85B
| $4.17M | ﹤0.01% |
177,269
+176,515
| +23,410% | +$3.9M |
|
2250
RingCentral
RNG
$5.66B
| $4.17M | ﹤0.01% |
146,969
-18,750
| -11% | -$484K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.